ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Samsung Biologics to make Moderna vaccine in Biden summit takeaway

Incheon production deal comes after Moon government faced criticism on supply front

Samsung Biologics will produce hundreds of millions of Moderna vaccines starting this summer. (Photo courtesy of Samsung Biologics)

SEOUL -- South Korean drugmaker Samsung Biologics will begin producing the Moderna coronavirus vaccine following an agreement struck during President Moon Jae-in's trip to Washington last week.

The company will produce hundreds of millions of vaccine doses at its facilities in Incheon and plans to ship the drug domestically and to other destinations excluding the U.S., according to Sunday's announcement.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more